{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T14:14:05Z","timestamp":1795011245455,"version":"4.9.1"},"reference-count":45,"publisher":"Wiley","issue":"10","license":[{"start":{"date-parts":[[2012,1,10]],"date-time":"2012-01-10T00:00:00Z","timestamp":1326153600000},"content-version":"vor","delay-in-days":70,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Pain"],"published-print":{"date-parts":[[2011,11]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Current treatments of neuropathic pain arising from conditions such as nerve injury\/compression are only partially effective, and limited in their use by side\u2010effects. p38 mitogen\u2010activated protein kinase (MAPK) is involved in the regulation and synthesis of inflammatory mediators, and is the target for a novel class of cytokine\u2010suppressive anti\u2010inflammatory drugs. p38 inhibitors may reduce neuronal sensitisation in preclinical models of neuropathic pain, particularly where there is a substantial inflammatory component. An exploratory, multicentre, double\u2010blind, placebo\u2010controlled, two\u2010period, cross\u2010over trial was undertaken to evaluate the effect of dilmapimod (SB\u2010681323), a selective p38 MAPK inhibitor, on neuropathic pain symptoms and signs. Fifty patients with nerve trauma, radiculopathy or carpal tunnel syndrome were randomised; 43 patients completed the study. Eligible patients received oral dilmapimod and placebo twice daily for 2 weeks, with an intervening washout period of 2\u20134 weeks. Subjects attended weekly for efficacy and safety assessments, which included evaluation of daily and current pain intensity using an 11\u2010point numerical rating scale (NRS), quantitative sensory testing, allodynia and global impression of change. There was a statistically significant reduction in the primary endpoint of average daily pain score during the second week of treatment among patients treated with dilmapimod (15 mg\/day) compared to placebo using NRS [0.80; 95% CI (0.28, 1.33);<jats:italic>p<\/jats:italic>= 0.0034]. A similar trend for effect was seen in some secondary endpoints. Dilmapimod was well tolerated, with no clinically relevant safety findings. p38 MAPK inhibitors merit further evaluation for neuropathic pain in larger clinical trials, particularly for clinically meaningful analgesic effect size.<\/jats:p>","DOI":"10.1016\/j.ejpain.2011.04.005","type":"journal-article","created":{"date-parts":[[2011,5,22]],"date-time":"2011-05-22T03:52:56Z","timestamp":1306036376000},"page":"1040-1048","source":"Crossref","is-referenced-by-count":155,"title":["Clinical trial of the p38 MAP kinase inhibitor dilmapimod in neuropathic pain following nerve injury"],"prefix":"10.1002","volume":"15","author":[{"given":"Praveen","family":"Anand","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ravikiran","family":"Shenoy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanne E.","family":"Palmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda J.","family":"Baines","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert Y.K.","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Robertson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nick","family":"Bird","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thor","family":"Ostenfeld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boris A.","family":"Chizh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2012,1,10]]},"reference":[{"key":"e_1_2_7_2_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M610987200"},{"key":"e_1_2_7_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neulet.2008.04.007"},{"key":"e_1_2_7_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/J.JHSB.2006.06.009"},{"key":"e_1_2_7_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pain.2008.01.006"},{"issue":"3","key":"e_1_2_7_6_1","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/S0022-3565(25)21307-6","article-title":"Pharmacological profile of SB 203580, a selective inhibitor of cytokine suppressive binding protein\/p38 kinase, in animal models of arthritis, bone resorption, endotoxin shock and immune function","volume":"279","author":"Badger A.M.","year":"1996","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_2_7_7_1","doi-asserted-by":"publisher","DOI":"10.2217\/ijr.09.63"},{"key":"e_1_2_7_8_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.24266"},{"key":"e_1_2_7_9_1","doi-asserted-by":"publisher","DOI":"10.1097\/ALN.0b013e3181a05aa0"},{"key":"e_1_2_7_10_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.24485"},{"key":"e_1_2_7_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pain.2008.03.002"},{"key":"e_1_2_7_12_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2377-6-1"},{"key":"e_1_2_7_13_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1085-9489.2004.09104.x"},{"key":"e_1_2_7_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpain.2007.09.005"},{"key":"e_1_2_7_15_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2377-7-11"},{"key":"e_1_2_7_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pain.2010.06.019"},{"key":"e_1_2_7_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pain.2005.02.032"},{"key":"e_1_2_7_18_1","doi-asserted-by":"publisher","DOI":"10.1186\/1472-6874-5-2"},{"key":"e_1_2_7_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pain.2007.12.011"},{"issue":"1","key":"e_1_2_7_20_1","first-page":"71","article-title":"Mitogen\u2010activated protein kinases as potential targets for pain killers","volume":"5","author":"Ji R.R.","year":"2004","journal-title":"Curr Opin Investig Drugs"},{"key":"e_1_2_7_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainresrev.2008.12.011"},{"key":"e_1_2_7_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0896-6273(02)00908-X"},{"key":"e_1_2_7_23_1","doi-asserted-by":"publisher","DOI":"10.1186\/1744-8069-3-33"},{"key":"e_1_2_7_24_1","doi-asserted-by":"publisher","DOI":"10.1006\/nbdi.2000.0360"},{"key":"e_1_2_7_25_1","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.23-10-04017.2003"},{"key":"e_1_2_7_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2007.12.002"},{"key":"e_1_2_7_27_1","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001554.pub2"},{"key":"e_1_2_7_28_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI25437"},{"key":"e_1_2_7_29_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1460-9568.2004.03754.x"},{"key":"e_1_2_7_30_1","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.3388-04.2004"},{"key":"e_1_2_7_31_1","doi-asserted-by":"publisher","DOI":"10.1177\/0091270002250615"},{"key":"e_1_2_7_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0079-6123(01)32103-9"},{"issue":"1","key":"e_1_2_7_33_1","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1302\/0301-620X.86B1.14344","article-title":"Correlation of nerve root pain with dermatomal sensory threshold and back pain with spinal movement in single level lumbar spondylosis","volume":"86","author":"Quraishi N.A.","year":"2004","journal-title":"J Bone Joint Surg Br"},{"key":"e_1_2_7_34_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.11358"},{"key":"e_1_2_7_35_1","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.110.209205"},{"key":"e_1_2_7_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0304-3959(02)00255-5"},{"key":"e_1_2_7_37_1","first-page":"335","volume-title":"Clinical pain management","author":"Shenoy R.","year":"2008"},{"key":"e_1_2_7_38_1","doi-asserted-by":"publisher","DOI":"10.1177\/0091270009347873"},{"key":"e_1_2_7_39_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature00894"},{"issue":"3","key":"e_1_2_7_40_1","first-page":"231","article-title":"Mitogen\u2010activated protein kinases and their role in regulation of cellular processes","volume":"21","author":"Strniskova M.","year":"2002","journal-title":"Gen Physiol Biophys"},{"key":"e_1_2_7_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pain.2004.02.016"},{"key":"e_1_2_7_42_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pain.2004.07.007"},{"key":"e_1_2_7_43_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroscience.2008.03.041"},{"key":"e_1_2_7_44_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clpt.2003.11.011"},{"key":"e_1_2_7_45_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tins.2004.12.002"},{"key":"e_1_2_7_46_1","doi-asserted-by":"publisher","DOI":"10.1002\/glia.10308"}],"container-title":["European Journal of Pain"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1016%2Fj.ejpain.2011.04.005","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1016%2Fj.ejpain.2011.04.005","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1016\/j.ejpain.2011.04.005","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T19:08:45Z","timestamp":1741201725000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1016\/j.ejpain.2011.04.005"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,11]]},"references-count":45,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2011,11]]}},"alternative-id":["10.1016\/j.ejpain.2011.04.005"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpain.2011.04.005","archive":["Portico"],"relation":{},"ISSN":["1090-3801","1532-2149"],"issn-type":[{"value":"1090-3801","type":"print"},{"value":"1532-2149","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,11]]}}}